Your email has been successfully added to our mailing list.

×
-0.0048400081475088 -0.000960242097401529 -0.000960242097401529 9.69941512524534E-06 0.0150437928592905 0.0683905760482643 0.0776050204172689 0.0831918835294231
Stock impact report

Stoke Therapeutics' Anti-Epilepsy Drug Candidate Shows Substantial, Sustained Reductions In Seizure Frequency In Pretreated Patients [Yahoo! Finance]

Stoke Therapeutics, Inc. (STOK) 
Last stoke therapeutics, inc. earnings: 11/12 08:00 am Check Earnings Report
Company Research Source: Yahoo! Finance
of children and adolescents ages 2 to 18 with Dravet syndrome who were treated with STK-001 Dravet syndrome is a severe and progressive genetic epilepsy characterized by frequent, prolonged, and refractory seizures. Data showed clinically meaningful effects, including substantial and durable reductions in convulsive seizure frequency and improvements in multiple measures of cognition and behavior. STK-001 has been generally well-tolerated in studies to date. Patients enrolled in these studies were highly refractory to treatment and taking the best available anti-seizure medicines: 85% of patients were taking at least three, and 54% were taking at least four medicines to control seizures. Half the patients in the studies were taking concomitant fenfluramine. New data from a combined analysis of 19 clinically evaluable patients treated with one, two, or three doses of 70mg demonstrated substantial reductions in convulsive seizure frequency compared to baseline at three months Show less Read more
Impact Snapshot
Event Time:
STOK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for STOK alerts
Opt-in for
STOK alerts

from News Quantified
Opt-in for
STOK alerts

from News Quantified